{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T09:36:59Z","timestamp":1793612219324,"version":"4.5.0"},"reference-count":68,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>D-dimers reflect a breakdown product of fibrin. The current narrative review outlines how D-dimers can arise in normal individuals, as well as in patients suffering from a wide range of disease states. D-dimers in normal individuals without evident thrombosis can arise from background fibrinolytic activity in various tissues, including kidney, mammary and salivary glands, which ensures smooth flow of arising fluids where any blood contamination could be immediately lysed. In addition, healthy individuals can also regularly sustain minor injuries, often unbeknown to them, and wound healing follows clot formation in these situations. D-dimers can also arise in anxiety and following exercise, and are also markers of inflammation. Lung inflammation (triggered by microbes or foreign particles) is perhaps also particularly relevant, since the hemostasis system and fibrinolysis help to trap and remove such debris. Lung inflammation in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may contribute to D-dimer levels additive to thrombosis in patients with COVID-19 (coronavirus disease 2019). Indeed, severe COVID-19 can lead to multiple activation events, including inflammation, primary and secondary hemostasis, and fibrinolysis, all of which may contribute to cumulative D-dimer development. Finally, D-dimer testing has also found a role in the diagnosis and triaging of the so-called (COVID-19) vaccine-induced thrombotic thrombocytopenia.<\/jats:p>","DOI":"10.1055\/s-0042-1748193","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T22:39:41Z","timestamp":1657319981000},"page":"672-679","source":"Crossref","is-referenced-by-count":40,"title":["D-dimers\u2014\u201cNormal\u201d Levels versus Elevated Levels Due to a Range of Conditions, Including \u201cD-dimeritis,\u201d Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19"],"prefix":"10.1055","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7218-0993","authenticated-orcid":false,"given":"Jecko","family":"Thachil","sequence":"additional","affiliation":[{"name":"Department of Haematology, Manchester University Hospitals, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2103-1661","authenticated-orcid":false,"given":"Emmanuel J.","family":"Favaloro","sequence":"additional","affiliation":[{"name":"Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia"},{"name":"Sydney Centres for Thrombosis and Haemostasis, Westmead, New South Wales, Australia"},{"name":"Faculty of Science and Health, Charles Sturt University, Wagga Wagga, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9523-9054","authenticated-orcid":false,"given":"Giuseppe","family":"Lippi","sequence":"additional","affiliation":[{"name":"Section of Clinical Biochemistry, University Hospital of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1515\/dx-2018-0099","article-title":"Understanding the \u201cphilosophy\u201d of laboratory hemostasis","volume":"6","author":"G Lippi","year":"2019","journal-title":"Diagnosis (Berl)"},{"issue":"03","key":"ref2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-0037-1607202","article-title":"Venous and arterial thromboses: two sides of the same coin?","volume":"44","author":"G Lippi","year":"2018","journal-title":"Semin Thromb Hemost"},{"issue":"04","key":"ref3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11239-010-0460-x","article-title":"Biochemical markers for the diagnosis of venous thromboembolism: the past, present and future","volume":"30","author":"G Lippi","year":"2010","journal-title":"J Thromb Thrombolysis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-1-4939-7196-1_7","article-title":"D-dimer testing: laboratory aspects and current issues","volume":"1646","author":"J Thachil","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"08","key":"ref5","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1080\/07853890802161015","article-title":"Help me, Doctor! My D-dimer is raised","volume":"40","author":"G Lippi","year":"2008","journal-title":"Ann Med"},{"issue":"01","key":"ref6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejim.2013.07.012","article-title":"Causes of elevated D-dimer in patients admitted to a large urban emergency department","volume":"25","author":"G Lippi","year":"2014","journal-title":"Eur J Intern Med"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jemermed.2008.07.033","article-title":"D-dimer measurement and laboratory feedback","volume":"37","author":"G Lippi","year":"2009","journal-title":"J Emerg Med"},{"issue":"03","key":"ref8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-0035-1549092","article-title":"International survey on D-dimer test reporting: a call for standardization","volume":"41","author":"G Lippi","year":"2015","journal-title":"Semin Thromb Hemost"},{"issue":"08","key":"ref9","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1515\/cclm-2020-0573","article-title":"Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation","volume":"58","author":"E J Favaloro","year":"2020","journal-title":"Clin Chem Lab Med"},{"issue":"09","key":"ref10","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1111\/jth.14956","article-title":"The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on fibrinolysis","volume":"18","author":"J Thachil","year":"2020","journal-title":"J Thromb Haemost"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(56)92048-7","article-title":"The biological significance of fibrinolysis","volume":"271","author":"T Astrup","year":"1956","journal-title":"Lancet"},{"issue":"03","key":"ref12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3181\/00379727-81-19983","article-title":"An activator of plasminogen in normal urine","volume":"81","author":"T Astrup","year":"1952","journal-title":"Proc Soc Exp Biol Med"},{"issue":"03","key":"ref13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3181\/00379727-84-20727","article-title":"A fibrinolytic system in human milk","volume":"84","author":"T Astrup","year":"1953","journal-title":"Proc Soc Exp Biol Med"},{"issue":"02","key":"ref14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1748-1716.1955.tb01272.x","article-title":"Fibrinolytic activity in human saliva","volume":"35","author":"O K Albrechtsen","year":"1955","journal-title":"Acta Physiol Scand"},{"issue":"03","key":"ref15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.blre.2014.10.003","article-title":"Platelet secretion: from haemostasis to wound healing and beyond","volume":"29","author":"E M Golebiewska","year":"2015","journal-title":"Blood Rev"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.thromres.2019.05.001","article-title":"Contribution of platelets, the coagulation and fibrinolytic systems to cutaneous wound healing","volume":"179","author":"A Opneja","year":"2019","journal-title":"Thromb Res"},{"issue":"04","key":"ref17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-0036-1571342","article-title":"What is the biological and clinical relevance of fibrin?","volume":"42","author":"R I Litvinov","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"04","key":"ref18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2141.1975.tb00876.x","article-title":"Chemotaxis and haemostasis","volume":"31","author":"A B Kay","year":"1975","journal-title":"Br J Haematol"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/path.1711450103","article-title":"Fibrin degradation and angiogenesis: quantitative analysis of the angiogenic response in the chick chorioallantoic membrane","volume":"145","author":"W D Thompson","year":"1985","journal-title":"J Pathol"},{"issue":"04","key":"ref20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1023\/A:1016076121918","article-title":"Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro","volume":"4","author":"C A Bootle-Wilbraham","year":"2001","journal-title":"Angiogenesis"},{"issue":"02","key":"ref21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.transci.2004.01.004","article-title":"Platelet gel for healing cutaneous chronic wounds","volume":"30","author":"G Crovetti","year":"2004","journal-title":"Transfus Apheresis Sci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/bmj.2.4321.541","article-title":"Human fibrin as dressing for burns","volume":"2","author":"R G Macfarlane","year":"1943","journal-title":"BMJ"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"c1475","DOI":"10.1136\/bmj.c1475","article-title":"Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts","volume":"340","author":"R A Douma","year":"2010","journal-title":"BMJ"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0140-6736(46)91840-5","article-title":"Observations on fibrinolysis; spontaneous activity associated with surgical operations, trauma, & c","volume":"2","author":"R G MacFARLANE","year":"1946","journal-title":"Lancet"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1182\/blood.V3.10.1167.1167","article-title":"Fibrinolysis; its mechanism and significance","volume":"3","author":"R G MacFarlane","year":"1948","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0140-6736(47)91226-9","article-title":"Observations on fibrinolysis; experimental activity produced by exercise or adrenaline","volume":"1","author":"R Biggs","year":"1947","journal-title":"Lancet"},{"issue":"04","key":"ref27","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0002-9343(02)01520-6","article-title":"Limitations of D-dimer testing in unselected inpatients with suspected venous thromboembolism","volume":"114","author":"D J Brotman","year":"2003","journal-title":"Am J Med"},{"issue":"04","key":"ref28","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1365-2141.2005.05652.x","article-title":"C-reactive protein and D-dimer with clinical probability score in the exclusion of pulmonary embolism","volume":"130","author":"N Steeghs","year":"2005","journal-title":"Br J Haematol"},{"key":"ref29","first-page":"323","article-title":"Symposium on inflammation and role of fibrin in the rheumatic diseases","volume":"14","author":"L E Glynn","year":"1963","journal-title":"Bull Rheum Dis"},{"issue":"04","key":"ref30","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0049-0172(82)90026-9","article-title":"The fibrinolytic system and its relation to inflammatory diseases","volume":"11","author":"I Clemmensen","year":"1982","journal-title":"Semin Arthritis Rheum"},{"issue":"01","key":"ref31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1172\/JCI200419569","article-title":"Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness","volume":"114","author":"S S Wagers","year":"2004","journal-title":"J Clin Invest"},{"issue":"05","key":"ref32","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/jth.15294","article-title":"Similarities and perspectives on the two C's-Cancer and COVID-19","volume":"19","author":"J Thachil","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref33","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1378\/chest.121.4.1262","article-title":"D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients","volume":"121","author":"A F Shorr","year":"2002","journal-title":"Chest"},{"issue":"06","key":"ref34","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1378\/chest.93.6.1256","article-title":"Role of enzymes mediating thrombosis and thrombolysis in lung disease","volume":"93","author":"H A Chapman Jr","year":"1988","journal-title":"Chest"},{"issue":"06","key":"ref35","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1164\/ajrccm\/137.6.1417","article-title":"Regulation of the procoagulant activity within the bronchoalveolar compartment of normal human lung","volume":"137","author":"H A Chapman","year":"1988","journal-title":"Am Rev Respir Dis"},{"issue":"03","key":"ref36","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1172\/JCI111275","article-title":"Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation","volume":"73","author":"H A Chapman Jr","year":"1984","journal-title":"J Clin Invest"},{"issue":"01","key":"ref37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1378\/chest.92.1.161","article-title":"Extracellular matrix injury during lung inflammation","volume":"92","author":"E J Campbell","year":"1987","journal-title":"Chest"},{"issue":"02","key":"ref38","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1164\/ajrccm\/137.2.412","article-title":"Role of plasminogen activator in degradation of extracellular matrix protein by live human alveolar macrophages","volume":"137","author":"H A Chapman Jr","year":"1988","journal-title":"Am Rev Respir Dis"},{"issue":"06","key":"ref39","first-page":"667","article-title":"Urokinase-type plasminogen activator in alveolar macrophages and bronchoalveolar lavage fluid from normal and smoke-exposed hamsters and humans","volume":"106","author":"R M Bowen","year":"1985","journal-title":"J Lab Clin Med"},{"issue":"14","key":"ref40","doi-asserted-by":"crossref","first-page":"8198","DOI":"10.1016\/S0021-9258(19)39057-X","article-title":"Alveolar epithelial cell plasminogen activator. Characterization and regulation","volume":"265","author":"B C Marshall","year":"1990","journal-title":"J Biol Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0002-9343(66)90129-X","article-title":"Effect of surface active lipoprotein on clotting and fibrinolysis, and of fibrinogen on surface tension of surface active lipoprotein","volume":"40","author":"F B Taylor Jr","year":"1960","journal-title":"Am J Med"},{"issue":"03","key":"ref42","first-page":"437","article-title":"Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease","volume":"133","author":"H A Chapman","year":"1986","journal-title":"Am Rev Respir Dis"},{"issue":"04","key":"ref43","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1164\/arrd.1987.135.4.930","article-title":"Tissue fibrin deposition during acute lung injury in rabbits and its relationship to local expression of procoagulant and fibrinolytic activities","volume":"135","author":"R G Sitrin","year":"1987","journal-title":"Am Rev Respir Dis"},{"issue":"03","key":"ref44","first-page":"443","article-title":"Intraluminal fibrosis in interstitial lung disorders","volume":"122","author":"F Basset","year":"1986","journal-title":"Am J Pathol"},{"issue":"11","key":"ref45","doi-asserted-by":"crossref","first-page":"693","DOI":"10.21037\/atm-20-3989","article-title":"COVID-19: unravelling the clinical progression of nature's virtually perfect biological weapon","volume":"8","author":"G Lippi","year":"2020","journal-title":"Ann Transl Med"},{"issue":"07","key":"ref46","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1055\/s-0040-1712155","article-title":"SARS-2 coronavirus-associated hemostatic lung abnormality in COVID-19: is it pulmonary thrombosis or pulmonary embolism?","volume":"46","author":"J Thachil","year":"2020","journal-title":"Semin Thromb Hemost"},{"issue":"07","key":"ref47","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1055\/s-0040-1710337","article-title":"Coronavirus disease 2019, prothrombotic factors, and venous thromboembolism","volume":"46","author":"S Schulman","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cca.2020.04.027","article-title":"Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: a novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis","volume":"507","author":"B M Henry","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"01","key":"ref49","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.mayocp.2020.10.031","article-title":"Coronavirus disease 2019-associated coagulopathy","volume":"96","author":"G Lippi","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"06","key":"ref50","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/jth.15327","article-title":"Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: a single-center prospective longitudinal study","volume":"19","author":"G K Juneja","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"05","key":"ref51","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jvsv.2021.01.012","article-title":"A systematic review and meta-analysis of incidence, prognosis, and laboratory indicators of venous thromboembolism in hospitalized patients with coronavirus disease 2019","volume":"9","author":"Y Liu","year":"2021","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"07","key":"ref52","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jamainternmed.2021.0488","article-title":"Incidence of 30-day venous thromboembolism in adults tested for SARS-CoV-2 infection in an integrated health care system in Northern California","volume":"181","author":"N H Roubinian","year":"2021","journal-title":"JAMA Intern Med"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1076029620987629","DOI":"10.1177\/1076029620987629","article-title":"Systemic coagulopathy in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis","volume":"27","author":"N Uaprasert","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"issue":"02","key":"ref54","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.mayocp.2020.11.018","article-title":"Arterial thrombotic events in adult inpatients with COVID-19","volume":"96","author":"M Fournier","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"05","key":"ref55","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1055\/s-0040-1709650","article-title":"D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis","volume":"120","author":"G Lippi","year":"2020","journal-title":"Thromb Haemost"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ajem.2020.09.018","article-title":"Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: a systematic review and meta-analysis","volume":"39","author":"B Gungor","year":"2021","journal-title":"Am J Emerg Med"},{"issue":"10","key":"ref57","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1161\/ATVBAHA.120.314872","article-title":"Prevalence and outcomes of D-dimer elevation in hospitalized patients with COVID-19","volume":"40","author":"J S Berger","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"09","key":"ref58","doi-asserted-by":"crossref","first-page":"e783","DOI":"10.1097\/CCM.0000000000004466","article-title":"Routine venous thromboembolism prophylaxis may be inadequate in the hypercoagulable state of severe coronavirus disease 2019","volume":"48","author":"T K Maatman","year":"2020","journal-title":"Crit Care Med"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.thromres.2020.08.032","article-title":"Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19","volume":"196","author":"L Naymagon","year":"2020","journal-title":"Thromb Res"},{"issue":"03","key":"ref60","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-0040-1709498","article-title":"Recommendations for minimal laboratory testing panels in patients with COVID-19: potential for prognostic monitoring","volume":"46","author":"E J Favaloro","year":"2020","journal-title":"Semin Thromb Hemost"},{"issue":"01","key":"ref61","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/ATVBAHA.120.315338","article-title":"COVID-19 and sepsis are associated with different abnormalities in plasma procoagulant and fibrinolytic activity","volume":"41","author":"E G Bouck","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2021.12.012","article-title":"Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19?","volume":"210","author":"N D Nielsen","year":"2022","journal-title":"Thromb Res"},{"issue":"07","key":"ref63","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1055\/s-0040-1715458","article-title":"Hematology laboratory abnormalities in patients with coronavirus disease 2019 (COVID-19)","volume":"46","author":"B Christensen","year":"2020","journal-title":"Semin Thromb Hemost"},{"issue":"04","key":"ref64","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1007\/s00330-021-08377-9","article-title":"What level of D-dimers can safely exclude pulmonary embolism in COVID-19 patients presenting to the emergency department?","volume":"432","author":"M P Revel","year":"2022","journal-title":"Eur Radiol"},{"issue":"01","key":"ref65","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11239-021-02527-y","article-title":"Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: Results from a Spanish multicenter registry (BIOCOVID-Spain study)","volume":"53","author":"L Garc\u00eda de Guadiana-Romualdo","year":"2022","journal-title":"J Thromb Thrombolysis"},{"issue":"12","key":"ref66","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/jamacardio.2021.3444","article-title":"Clinical characteristics and pharmacological management of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with cerebral venous sinus thrombosis: a review","volume":"6","author":"J G Rizk","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"04","key":"ref67","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/ijlh.13629","article-title":"Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia","volume":"43","author":"E J Favaloro","year":"2021","journal-title":"Int J Lab Hematol"},{"issue":"01","key":"ref68","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-0041-1736168","article-title":"Cerebral venous thrombosis developing after COVID-19 vaccination: VITT, VATT, TTS, and more","volume":"48","author":"G Lippi","year":"2022","journal-title":"Semin Thromb Hemost"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0042-1748193.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T12:57:24Z","timestamp":1730811444000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0042-1748193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":68,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2022,10,12]]},"published-print":{"date-parts":[[2022,9]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0042-1748193","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]}}}